PCH
IMCR icon

Polar Capital Holdings’s Immunocore IMCR Stock Holding History

Polar Capital Holdings’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-114,023
Closed -$3.36M – 303
2024
Q4 		$3.36M Sell
114,023
-387,732
-77% -$12.3M 0.02% 259
2024
Q3 		$15.6M Sell
501,755
-815
-0.2% -$29.6K 0.07% 165
2024
Q2 		$17M Buy
502,570
+1,270
+0.3% +$64.8K 0.1% 152
2024
Q1 		$32.6M Hold
501,300
– – 0.17% 111
2023
Q4 		$34.2M Buy
501,300
+251,300
+101% +$13.1M 0.21% 103
2023
Q3 		$13M Buy
250,000
+207,664
+491% +$12.3M 0.1% 164
2023
Q2 		$2.54M Buy
+42,336
New +$2.42M 0.01% 250

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Polar Capital Holdings's IMCR Position: Q1 2025 in Review

Polar Capital Holdings sold out of Immunocore (IMCR) in Q1 2025, closing a stake of 114,023 shares — an estimated $3.36M sold.

Polar Capital Holdings first reported a position in IMCR in Q2 2023 and held it in 7 quarters. The position peaked at $34.2M in Q4 2023. 116 funds tracked by Wall St. Rank hold IMCR as of Q1 2025.

  • Polar Capital Holdings reported no remaining Immunocore position as of Q1 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 114,023 Immunocore shares in Q1 2025, an estimated $3.36M.
  • Polar Capital Holdings first reported a position in Immunocore in Q2 2023 and held it in 7 quarters.
  • Polar Capital Holdings's Immunocore position peaked at $34.2M in Q4 2023.
  • 116 funds tracked by Wall St. Rank held Immunocore as of Q1 2025.

Based on Polar Capital Holdings's 13F filing for Q1 2025, filed 15 May 2025.